MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Substantia nigra T1 maps for the diagnosis of Parkinson’s disease

    C. Juri, L. Tapia, J. Cruz, S. Uribe, M. Andia (Santiago, Chile)

    Objective: To evaluate if the T1 value (measured in ms) in the substantia nigra (SN) is reduced in Parkinson disease (PD) patients as compared with…
  • 2018 International Congress

    Combining PET imaging and blood metabolomics data to improve machine learning models for Parkinson’s disease diagnosis

    E. Glaab, A. Greuel, J.P. Trezzi, C. Jäger, Z. Hodak, L. Timmermann, M. Tittgemeyer, N. Diederich (Esch-sur-Alzette, Luxembourg)

    Objective: To investigate whether the integration of PET imaging and metabolomics data can provide improved machine learning models for PD diagnosis. Background: The reliable diagnosis…
  • 2018 International Congress

    Brain responses evoked by thalamic and subthalamic deep brain stimulation

    J. Hirschmann, C. Hartmann, J. Vesper, L. Wojtecki, M. Butz, A. Schnitzler (Düsseldorf, Germany)

    Objective: To reveal how the pattern of evoked responses differs between deep brain stimulation (DBS) of the ventral intermediate nucleus of the thalamus (VIM) and…
  • 2018 International Congress

    Diminished fMRI global signal differences between eyes closed and eyes open resting state in RBD and PD

    J. Suescun, M. Schiess, L. Giancardo, R. Castriotta, T. Ellmore (Houston, TX, USA)

    Objective: test whether patients with Parkinson’s diseases (PD) and REM sleep behavior disorder (RBD) exhibit diminished state-related changes in their resting state fMRI global signal.…
  • 2018 International Congress

    Contribution of individual motor signs to striatal dopamine deficiency in parkinsonism

    E. Mäkinen, J. Joutsa, E. Jaakkola, T. Noponen, J. Johansson, M. Pitkonen, R. Levo, T. Mertsalmi, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: The primary aim of the study was to investigate if any individual motor sign could be used clinically to predict striatal dopamine deficiency. Secondary…
  • 2018 International Congress

    New approach to assess changes in brain activation during real walking using EEG

    I. Maidan, S. Shustak, T. Shiner, N. Giladi, J. Hausdorff, A. Mirelman (Tel Aviv, Israel)

    Objective: To examine the use of EEG during the performance of two well-known paradigms, dual task and oddball, to reveal changes in brain activation during…
  • 2018 International Congress

    Improvement of antisaccade amplitude by the STN DBS and target eccentricity

    A. Yugeta, Y. Terao, Y. Ugawa (Tokyo, Japan)

    Objective: To investigate the dependency of antisaccade (AS) amplitude improvement by the subthalamic nucleus (STN) deep brain stimulation (DBS) on the target eccentricity in Parkinson’s…
  • 2018 International Congress

    Non-invasive, automated corneal nerve quantification reveals neurodegeneration in Parkinson’s disease: A potential novel imaging biomarker

    S. Lim, M. Ferdousi, A. Kalteniece, C. Kobylecki, R. Malik, M. Silverdale (Salford, United Kingdom)

    Objective: The aim of the study is to use automated analysis of corneal confocal microscopy (CCM) images to allow rapid and reliable quantification of corneal…
  • 2018 International Congress

    Longitudinal development of nigral iron load in Parkinson’s Disease

    S. Franthal, L. Pirpamer, C. Rodler, N. Homayoon, M. Koegl, P. Katschnig-Winter, K. Wenzel, C. Langkammer, S. Ropele, R. Schmidt, P. Schwingenschuh (Graz, Austria)

    Objective: We for the first time investigated longitudinal changes of nigral iron load in Parkinson’s disease (PD) measured by Quantitative Susceptibility Mapping (QSM), a highly…
  • 2018 International Congress

    Cognitive networks in Parkinson’s Disease Mild Cognitive Impairment: Salience Network disruption without gray matter loss

    I. Aracil, F. Sampedro, J. Marin, J. Perez, H. Bejr-Kasem, S. Martinez-Horta, A. Horta, M. Boti, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To identify neural correlates of mild cognitive impairment in Parkinson’s disease (PD-MCI) according to Level-I Movement Disorders Task Force Criteria (MDS-TF) (1), using a…
  • « Previous Page
  • 1
  • …
  • 1331
  • 1332
  • 1333
  • 1334
  • 1335
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley